23andMe's genome test launches in UK after US ban
This article was originally published in Scrip
Executive Summary
23andMe, a genetic testing firm which entered a partnership in September with Pfizer to push the idea of personalized medicines (scripintelligence.com, 1 September 2014), has launched its Personal Genome Service in the UK – a program that has been banned in the US.